US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Respiratory/Pulmonary Market Research Reports & Industry Analysis

RSS Feeds

Respiratory/Pulmonary Industry Research & Market Reports

1    3    5  6  7  8  9  10  
2014 Analysis of Respiratory Diseases in France: Market Outlook and Emerging Opportunities
11/25/2013 | published by: VPGMarketResearch.com
... forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.  The report provides test volume and sales projections for Hospitals and Commercial/Private Labs.  In addition to market share and sales forecasts, ...  |  read more...
USD 1,950
2014 Opportunities in the French Respiratory Diseases Diagnostic Testing Market
12/6/2013 | published by: VPGMarketResearch.com
... supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.  The report provides test volume and sales projections for Hospitals and Commercial/Private Labs.  In addition to market share and sales forecasts, the report: ...  |  read more...
USD 1,950
2014 Analysis of Respiratory Diseases in Germany: Market Outlook and Emerging Opportunities
11/25/2013 | published by: VPGMarketResearch.com
... forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.  The report provides test volume and sales projections for Hospitals and Commercial/Private Labs.  In addition to market share and sales forecasts, ...  |  read more...
USD 1,950
2014 Opportunities in the German Respiratory Diseases Diagnostic Testing Market
12/6/2013 | published by: VPGMarketResearch.com
... supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.  The report provides test volume and sales projections for Hospitals and Commercial/Private Labs.  In addition to market share and sales forecasts, the report: ...  |  read more...
USD 1,950
2014 Analysis of Respiratory Diseases in Spain: Market Outlook and Emerging Opportunities
11/25/2013 | published by: VPGMarketResearch.com
... forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.  The report provides test volume and sales projections for Hospitals and Commercial/Private Labs.     In addition to market share and sales forecasts, ...  |  read more...
USD 1,950
2014 Analysis of Respiratory Diseases in the US: Market Outlook and Emerging Opportunities
11/25/2013 | published by: VPGMarketResearch.com
... sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.  The report provides test volume and sales projections for Hospitals, Physician Offices, Commercial, and Public Health Labs. In addition to ...  |  read more...
USD 3,600
2014Opportunities in the Pneumonia Diagnostic Testing Market
12/6/2013 | published by: VPGMarketResearch.com
... Pneumonia definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments:      - Hospitals      - Commercial/Private Labs     ...  |  read more...
USD 4,350
2014 Opportunities in the European Respiratory Diseases Diagnostic Testing Market
12/6/2013 | published by: VPGMarketResearch.com
... European respiratory disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.  About this Report This report presents detailed analysis of the Respiratory Disease market ...  |  read more...
USD 8,300
2014 Opportunities in the Global Respiratory Diseases Diagnostic Testing Market
12/6/2013 | published by: VPGMarketResearch.com
... provides analysis of the global respiratory disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.  About this Report This report presents detailed analysis of ...  |  read more...
USD 9,850
Respiratory Diseases in France 2014: Market Outlook and Emerging Opportunities
1/23/2014 | published by: VPGMarketResearch.com
... Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume and sales projections for Hospitals and Commercial/Private Labs. In addition to market share and sales forecasts, the report: - Examines market ...  |  read more...
USD 1,950
2014 Strategies for the German Respiratory Diseases Diagnostic Testing Market
1/29/2014 | published by: VPGMarketResearch.com
... supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume and sales projections for Hospitals and Commercial/Private Labs. In addition to market share and sales forecasts, the report: ...  |  read more...
USD 1,950
2014 Strategies for the Japanese Respiratory Diseases Diagnostic Testing Market
1/29/2014 | published by: VPGMarketResearch.com
... supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume and sales projections for Hospitals and Commercial/Private Labs. In addition to market share and sales forecasts, the report: ...  |  read more...
USD 2,400
2014 Strategies for the Spanish Respiratory Diseases Diagnostic Testing Market
1/29/2014 | published by: VPGMarketResearch.com
... supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume and sales projections for Hospitals and Commercial/Private Labs. In addition to market share and sales forecasts, the report: ...  |  read more...
USD 1,950
2014 Strategies for the UK Respiratory Diseases Diagnostic Testing Market
1/29/2014 | published by: VPGMarketResearch.com
... supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume and sales projections for Hospitals, Commercial and Public Health Labs. In addition to market share and sales forecasts, ...  |  read more...
USD 1,950
2014 Strategies for the US Respiratory Diseases Diagnostic Testing Market
1/29/2014 | published by: VPGMarketResearch.com
... supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume and sales projections for Hospitals, Physician Offices, Commercial, and Public Health Labs. In addition to market share and ...  |  read more...
USD 3,600
Chronic Obstructive Pulmonary Disorder (COPD) - KOL Insight and Consensus Outlook
1/20/2014 | published by: FirstWord
... a 5 year CAGR of 7.1% this high growth sector is set for radical change as new products and combinations are introduced changing both the treatment and competitive landscapes. The cosy carve up of the ...  |  read more...
USD 7,495
Market Highlights: UK Bronchitis – 2014
5/1/2014 | published by: Fore Pharma
... market size estimates for 2013, market share forecast for six years to 2019, bronchitis drugs market share, bronchitis drugs sales estimates, bronchitis drugs sales forecast, and bronchitis late stage pipeline products.This research helps executives track ...  |  read more...
USD 990
Market Highlights: Europe Bronchitis – 2014
5/1/2014 | published by: Fore Pharma
... research includes Europe (Germany, France, Italy, Spain, and UK) bronchitis market size estimates for 2013, market share forecast for six years to 2019, bronchitis drugs market share, bronchitis drugs sales estimates, bronchitis drugs sales forecast, ...  |  read more...
USD 2,800
Market Highlights: France Chronic Obstructive Pulmonary Disease – 2014
5/1/2014 | published by: Fore Pharma
... pulmonary disease drug sales forecast in France. The research includes France chronic obstructive pulmonary disease market size estimates for 2013, market share forecast for six years to 2019, chronic obstructive pulmonary disease drugs market share, ...  |  read more...
USD 990
Cystic Fibrosis - Pipeline Review, H1 2014
4/28/2014 | published by: Global Markets Direct
... therapeutic development for Cystic Fibrosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
2014 U.S. Patient care - Respiratory system sold through Offices of physicians-Product & Services Report
4/15/2014 | published by: Barnes Reports
... Barnes Reports, contains timely and accurate industry statistics, forecasts and demographics. The report features 2014 current and 2015 forecast estimates on the sales of Patient care - Respiratory system sold through Offices of physicians nationally ...  |  read more...
USD 199
Market Highlights: US Chronic Obstructive Pulmonary Disease – 2014
5/1/2014 | published by: Fore Pharma
... obstructive pulmonary disease drug sales forecast in the US. The research includes the US chronic obstructive pulmonary disease market size estimates for 2013, market share forecast for six years to 2019, chronic obstructive pulmonary disease ...  |  read more...
USD 990
Cystic Fibrosis Therapeutics in Major Developed Markets to 2019 - CFTR Modulators Initiate Drive towards Personalized Treatment and Market Growth
2/7/2014 | published by: GBI Research
... “Cystic Fibrosis Therapeutics in Major Developed Markets to 2019 - CFTR Modulators Initiate Drive towards Personalized Treatment and Market Growth”. The value of the Cystic Fibrosis (CF) market is expected to increase significantly in value ...  |  read more...
USD 4,995
Update: Idiopathic Pulmonary Fibrosis Pipeline Highlights – 2014
5/1/2014 | published by: Fore Pharma
... It covers emerging therapies for Idiopathic Pulmonary Fibrosis in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating ...  |  read more...
USD 590
US Respiratory Measurement Devices : Market Report
4/28/2014 | published by: ABMRG
... report include: Capnograph Pulse Oximeter Systems Spirometers Scope The report highlights historic and forecasted market size in terms of revenues & unit sales, average selling price, growth rates, and company market shares. Highlights and compares ...  |  read more...
USD 2,100
1    3    5  6  7  8  9  10